These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33421481)

  • 1. Coming full circle (almost): Low dose oral minoxidil for alopecia.
    Heymann WR
    J Am Acad Dermatol; 2021 Mar; 84(3):613-614. PubMed ID: 33421481
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose oral minoxidil as treatment for non-scarring alopecia: a systematic review.
    Sharma AN; Michelle L; Juhasz M; Muller Ramos P; Atanaskova Mesinkovska N
    Int J Dermatol; 2020 Aug; 59(8):1013-1019. PubMed ID: 32516434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of very-low-dose oral minoxidil 1.25 mg in male androgenetic alopecia.
    Jha AK; Sonthalia S; Zeeshan MD; Vinay K
    J Am Acad Dermatol; 2020 Nov; 83(5):1491-1493. PubMed ID: 32492469
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia.
    Jimenez-Cauhe J; Saceda-Corralo D; Rodrigues-Barata R; Hermosa-Gelbard A; Moreno-Arrones OM; Fernandez-Nieto D; Vaño-Galvan S
    J Am Acad Dermatol; 2019 Aug; 81(2):648-649. PubMed ID: 31054970
    [No Abstract]   [Full Text] [Related]  

  • 5. Side effects of low-dose oral minoxidil for treating alopecia.
    Beach RA; McDonald KA; Barrett BM; Abdel-Qadir H
    J Am Acad Dermatol; 2021 May; 84(5):e239-e240. PubMed ID: 33359594
    [No Abstract]   [Full Text] [Related]  

  • 6. Diffuse hypertrichosis during treatment with 5% topical minoxidil.
    Peluso AM; Misciali C; Vincenzi C; Tosti A
    Br J Dermatol; 1997 Jan; 136(1):118-20. PubMed ID: 9039309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitization to saw palmetto and minoxidil in separate topical extemporaneous treatments for androgenetic alopecia.
    Sinclair RD; Mallari RS; Tate B
    Australas J Dermatol; 2002 Nov; 43(4):311-2. PubMed ID: 12423443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The therapy of androgenetic alopecia with minoxidil].
    Bammel A; Stern R; Sterry W
    Dtsch Med Wochenschr; 1993 May; 118(21):787-9. PubMed ID: 8504714
    [No Abstract]   [Full Text] [Related]  

  • 9. Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: A randomized clinical trial.
    Ramos PM; Sinclair RD; Kasprzak M; Miot HA
    J Am Acad Dermatol; 2020 Jan; 82(1):252-253. PubMed ID: 31473295
    [No Abstract]   [Full Text] [Related]  

  • 10. Comment on "Low dose oral minoxidil for treating alopecia: A 3-year North American retrospective case series": Adding further evidence about side effects.
    Ortega-Quijano D; Jimenez-Cauhe J; Fernandez-Nieto D; Saceda-Corralo D; Vaño-Galvan S
    J Am Acad Dermatol; 2021 May; 84(5):e237-e238. PubMed ID: 33359596
    [No Abstract]   [Full Text] [Related]  

  • 11. Off-Label Use of Topical Minoxidil in Alopecia: A Review.
    Stoehr JR; Choi JN; Colavincenzo M; Vanderweil S
    Am J Clin Dermatol; 2019 Apr; 20(2):237-250. PubMed ID: 30604379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case series of oral minoxidil for androgenetic and traction alopecia: Tolerability & the five C's of oral therapy.
    Beach RA
    Dermatol Ther; 2018 Nov; 31(6):e12707. PubMed ID: 30246901
    [No Abstract]   [Full Text] [Related]  

  • 13. Alopecia and ocular alterations: a role for Minoxidil?
    Rastmanesh R
    J Recept Signal Transduct Res; 2010 Jun; 30(3):189-92. PubMed ID: 20415543
    [No Abstract]   [Full Text] [Related]  

  • 14. [Minoxidil--a hope for patients with androgen alopecia?].
    Mørk C; Braathen LR
    Tidsskr Nor Laegeforen; 1988 Oct; 108(28):2391-3. PubMed ID: 3061060
    [No Abstract]   [Full Text] [Related]  

  • 15. Rabbit syndrome because of topical minoxidil foam.
    Nagar R
    Dermatol Ther; 2015; 28(3):112-3. PubMed ID: 25817819
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical minoxidil for baldness.
    Med Lett Drugs Ther; 1987 Sep; 29(749):87-8. PubMed ID: 3306300
    [No Abstract]   [Full Text] [Related]  

  • 17. [Toxic effects of 2% minoxidil].
    Rigoni C; Pinelli S; Menni S
    G Ital Dermatol Venereol; 1988 Nov; 123(11):609-10. PubMed ID: 3254343
    [No Abstract]   [Full Text] [Related]  

  • 18. Allergic contact dermatitis to minoxidil.
    Degreef H; Hendrickx I; Dooms-Goossens A
    Contact Dermatitis; 1985 Sep; 13(3):194-5. PubMed ID: 2932293
    [No Abstract]   [Full Text] [Related]  

  • 19. Controversies in the treatment of androgenetic alopecia: The history of finasteride.
    Andy G; John M; Mirna S; Rachita D; Michael K; Maja K; Aseem S; Zeljana B
    Dermatol Ther; 2019 Mar; 32(2):e12647. PubMed ID: 30253001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.